Cephalon(CEPH)
Cephalon, Inc. was an American biopharmaceutical company co-founded in 1987 by pharmacologist Frank Baldino, Jr., neuroscientist Michael Lewis, and organic chemist James C. Kauer—all three former scientists with the DuPont Company.[not verified in body] Baldino served as Cephalon's chairman and chief executive officer,[not verified in body] until his death in December 2010. The company's name comes from the adjective "cephalic" meaning "related to the head or brain", as it was established primarily to pursue treatments for neurodegenerative diseases.[not verified in body]
Download report
Favorite
Financial
Marketed Drugs
Clinical Trials
Financial
Stock price
*Currency in USD
Company Revenue
No data
Revenue by Drug
Marketed Drugs
Therapeutic Areas:
All
Classification:
All
Include Generics:
Trade Name | Drug Name | Approved | Patent Expires | Indication |
|---|---|---|---|---|
| Actiq | Fentanyl | 1998-11-04 | 2024-2033 | |
| Fentanyl | Fentanyl | 1993-10-04 | 2024-2033 | |
| Fentora | Fentanyl | 2006-09-25 | 2024-2033 | |
| Gabitril | Tiagabine | 1997-09-30 | ||
| Nuvigil | Armodafinil | 2007-06-15 | ||
| Provigil | Modafinil | 1998-12-24 | ||
| Treanda | Bendamustine | 2008-03-20 | 2026-2042 | |
| Trisenox | Arsenic trioxide | 2000-09-25 |
Clinical Trials
Therapeutic Areas:
All
Classification:
All
Approval:
All
Status:
All
Phases:
All
Drug Name | Phase 1 | Phase 2 | Phase 3 | Phase 4 | Indication |
|---|---|---|---|---|---|
1
2
3
4
>
© 2020-2024 Collaborative Drug Discovery Inc. (CDD) | Terms of Use